Stock listing
600267 Stock Price, News, Filings & Events — Zhejiang Hisun Pharmaceutical Co., Ltd. Class A
Selected listing: 600267 · SSE · CNY · CN
600267:SSE is the primary listing for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A, a company engaged in the pharmaceutical industry, specializing in the development and production of a range of medications. With a market capitalization of approximately 2.04 billion USD, the company plays a significant role in the healthcare sector. Recent news and filings may provide insights into its business strategies and market performance, reflecting its ongoing commitment to innovation and growth in pharmaceuticals.
- Ticker
- 600267:SSE
- Asset type
- Stock
- Market cap
- $2.05B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SSE
- Currency
- CNY
Zhejiang Hisun Pharmaceutical Co., Ltd. Class A 600267:SSE stock context
600267:SSE is the primary listing for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A, a company engaged in the pharmaceutical industry, specializing in the development and production of a range of medications. With a market capitalization of approximately 2.04 billion USD, the company plays a significant role in the healthcare sector. Recent news and filings may provide insights into its business strategies and market performance, reflecting its ongoing commitment to innovation and growth in pharmaceuticals.
Research Zhejiang Hisun Pharmaceutical Co., Ltd. Class A
Zhejiang Hisun Pharmaceutical Co., Ltd. Class A investor report
Review AI stock analysis and investor report context for 600267:SSE.
Zhejiang Hisun Pharmaceutical Co., Ltd. Class A company profile
View the public company page for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A on 6ix.
Zhejiang Hisun Pharmaceutical Co., Ltd. Class A news
Read company news and market updates connected to Zhejiang Hisun Pharmaceutical Co., Ltd. Class A.
Zhejiang Hisun Pharmaceutical Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A.